These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 33794838
21. Denosumab: a new treatment option for giant cell tumor of bone. Lewin J, Thomas D. Drugs Today (Barc); 2013 Nov; 49(11):693-700. PubMed ID: 24308016 [Abstract] [Full Text] [Related]
22. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab. Palmerini E, Seeger LL, Gambarotti M, Righi A, Reichardt P, Bukata S, Blay JY, Dai T, Jandial D, Picci P. BMC Cancer; 2021 Jan 22; 21(1):89. PubMed ID: 33482769 [Abstract] [Full Text] [Related]
23. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial. Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T. Ann Oncol; 2015 Oct 22; 26(10):2149-54. PubMed ID: 26205395 [Abstract] [Full Text] [Related]
24. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E. Lancet Oncol; 2019 Dec 22; 20(12):1719-1729. PubMed ID: 31704134 [Abstract] [Full Text] [Related]
25. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series. Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A. J Clin Pathol; 2016 Mar 22; 69(3):240-7. PubMed ID: 26338802 [Abstract] [Full Text] [Related]
26. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H. Eur Spine J; 2017 May 22; 26(Suppl 1):236-242. PubMed ID: 28396950 [Abstract] [Full Text] [Related]
27. Histological and immunohistochemical analyses of osteoclast maturation in giant cell tumor of bone. Agawa R, Kato I, Kawabata Y, Takeyama M, Fujii S. Pathol Res Pract; 2024 Feb 22; 254():155128. PubMed ID: 38244437 [Abstract] [Full Text] [Related]
28. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses. Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R, Ohashi K. Histopathology; 2018 May 22; 72(6):914-922. PubMed ID: 29206281 [Abstract] [Full Text] [Related]
29. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls. Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA. Hum Pathol; 2017 May 22; 63():89-97. PubMed ID: 28235628 [Abstract] [Full Text] [Related]
30. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report. Watanabe N, Matsumoto S, Shimoji T, Ae K, Tanizawa T, Gokita T, Motoi N, Ueno T, Koizumi M. BMC Res Notes; 2014 Sep 05; 7():608. PubMed ID: 25193435 [Abstract] [Full Text] [Related]
31. Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation. Lejoly M, Van Den Berghe T, Creytens D, Huysse W, Lapeire L, Sys G, Verstraete K. Skeletal Radiol; 2024 Feb 05; 53(2):353-364. PubMed ID: 37515643 [Abstract] [Full Text] [Related]
32. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab. Tsukamoto S, Righi A, Vanel D, Honoki K, Donati DM, Errani C. Jpn J Clin Oncol; 2017 Nov 01; 47(11):1090-1096. PubMed ID: 29048579 [Abstract] [Full Text] [Related]
33. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report. Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW. JBJS Case Connect; 2016 Nov 01; 6(3):e74. PubMed ID: 29252651 [Abstract] [Full Text] [Related]
34. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]
35. Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine: A Case Report. Law GW, Yeo NEM, Howe TS, Tan YZ, Tan SB, Siddiqui MMA. Spine (Phila Pa 1976); 2018 May 01; 43(9):E551-E556. PubMed ID: 29016442 [Abstract] [Full Text] [Related]
36. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases. Kumar R, Mallya V, Mandal S, Tomar R, Khurana N, Maini L. J Cancer Res Ther; 2023 May 01; 19(3):768-772. PubMed ID: 37470608 [Abstract] [Full Text] [Related]
37. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images. Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS. J Orthop Sci; 2018 May 01; 23(3):570-577. PubMed ID: 29429890 [Abstract] [Full Text] [Related]
38. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum. Liang H, Liu X, Yang Y, Guo W, Yang R, Tang X, Yan T, Li Y, Tang S, Li D, Qu H, Dong S, Ji T, Du Z, Zang J. Spine (Phila Pa 1976); 2022 May 01; 47(9):691-701. PubMed ID: 34961753 [Abstract] [Full Text] [Related]
39. Current concepts in the treatment of giant cell tumour of bone. van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H. Curr Opin Oncol; 2020 Jul 01; 32(4):332-338. PubMed ID: 32541321 [Abstract] [Full Text] [Related]
40. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J. Arch Orthop Trauma Surg; 2019 Oct 01; 139(10):1339-1349. PubMed ID: 30877429 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]